Acrivon Therapeutics Dividend
Dividend criteria checks 0/6
Acrivon Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 2.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -US$2.08 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Here's Why We're Not Too Worried About Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Situation
Mar 29
Acrivon Therapeutics (NASDAQ:ACRV) Is In A Good Position To Deliver On Growth Plans
Oct 05Acrivon Therapeutics (NASDAQ:ACRV) Is In A Good Position To Deliver On Growth Plans
Jun 22We Think Acrivon Therapeutics (NASDAQ:ACRV) Can Afford To Drive Business Growth
Feb 22Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if ACRV's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ACRV's dividend payments have been increasing.
Dividend Yield vs Market
| Acrivon Therapeutics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (ACRV) | n/a |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.8% |
| Industry Average (Biotechs) | 2.8% |
| Analyst forecast in 3 Years (ACRV) | n/a |
Notable Dividend: Unable to evaluate ACRV's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ACRV's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate ACRV's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ACRV has not reported any payouts.